Amended Statement of Changes in Beneficial Ownership (4/a)
21 Dicembre 2020 - 5:09PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
SCHWARTZ ALICE N |
2. Issuer Name and Ticker or Trading Symbol
BIO-RAD LABORATORIES, INC.
[
BIO BIOB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/4/2020 |
|
(Street)
HERCULES, CA 94547
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
12/14/2020 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Bio-Rad A Common Stock | 12/7/2020 | | G |
V
| 1800 (1) | D | $.00 | 1791821 | I | By Alice N. Schwartz Revocable Trust |
| Bio-Rad A Common Stock | | | | | | | | 90 | I | By David Schwartz Exemption Trust |
| Bio-Rad A Common Stock | | | | | | | | 240 | I | By David Schwartz Exempt Martial Trust |
| Bio-Rad A Common Stock | | | | | | | | 898931 | I | By David Schwartz Non-Exempt Martial Trust |
| Bio-Rad A Common Stock | | | | | | | | 34311 | I | By Charitable Remainder Unitrust |
| Bio-Rad B Common Stock | 12/4/2020 | | G |
V
| 162 (1) | D | $.00 | 438518 | I | By Alice N. Schwartz Revocable Trust |
| Bio-Rad B Common Stock | | | | | | | | 57000 | I | By David Schwartz Non-Exempt Martial Trust |
| Bio-Rad B Common Stock | | | | | | | | 4060054 | I | By Blue Raven Partners, L.P. (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | The Form 4 is being amended only to add the reporting person's name on the signature line. |
| (2) | The shares are held by a limited partnership of which the reporting person is a limited and general partner. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
SCHWARTZ ALICE N
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547 | X | X |
|
|
Signatures
|
| /s/ Alice N. Schwartz | | 12/18/2020 |
| **Signature of Reporting Person | Date |
Grafico Azioni Bio Rad Laboratories (NYSE:BIO.B)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Bio Rad Laboratories (NYSE:BIO.B)
Storico
Da Giu 2023 a Giu 2024
